| 192.43 5.88 (3.15%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 226.05 |
1-year : | 264.03 |
| Resists | First : | 193.53 |
Second : | 226.05 |
| Pivot price | 185.1 |
|||
| Supports | First : | 184.71 |
Second : | 179.25 |
| MAs | MA(5) : | 187.38 |
MA(20) : | 184.44 |
| MA(100) : | 201.45  |
MA(250) : | 199.63 |
|
| MACD | MACD : | 0 |
Signal : | -1 |
| %K %D | K(14,3) : | 68.4 |
D(3) : | 63.7 |
| RSI | RSI(14): 59.9 |
|||
| 52-week | High : | 236.89 | Low : | 162.72 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ VEEV ] has closed above the upper band by 11.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 38.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 193.72 - 194.46 | 194.46 - 195.32 |
| Low: | 184.33 - 185.12 | 185.12 - 186.03 |
| Close: | 190.93 - 192.22 | 192.22 - 193.71 |
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Fri, 26 Jul 2024
UniSuper Management Pty Ltd Purchases 1,100 Shares of Veeva Systems Inc. (NYSE:VEEV) - Defense World
Fri, 26 Jul 2024
O Shaughnessy Asset Management LLC Buys 1,020 Shares of Veeva Systems Inc. (NYSE:VEEV) - Defense World
Fri, 26 Jul 2024
Natixis Decreases Stock Position in Veeva Systems Inc. (NYSE:VEEV) - MarketBeat
Fri, 26 Jul 2024
Veeva Systems Inc. (NYSE:VEEV) Stake Trimmed by Covestor Ltd - Defense World
Fri, 26 Jul 2024
Zacks Research Comments on Veeva Systems Inc.’s FY2025 Earnings (NYSE:VEEV) - Defense World
Thu, 25 Jul 2024
Veeva Systems Inc. (NYSE:VEEV) Shares Bought by CANADA LIFE ASSURANCE Co - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 162 (M) |
| Shares Float | 148 (M) |
| Held by Insiders | 8.9 (%) |
| Held by Institutions | 83.7 (%) |
| Shares Short | 2,170 (K) |
| Shares Short P.Month | 2,180 (K) |
| EPS | 3.39 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 30.25 |
| Profit Margin | 22.3 % |
| Operating Margin | 24.6 % |
| Return on Assets (ttm) | 5.8 % |
| Return on Equity (ttm) | 12.5 % |
| Qtrly Rev. Growth | 23.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 15.4 |
| EBITDA (p.s.) | 3.47 |
| Qtrly Earnings Growth | 21 % |
| Operating Cash Flow | 1,170 (M) |
| Levered Free Cash Flow | 1,060 (M) |
| PE Ratio | 56.76 |
| PEG Ratio | 2.1 |
| Price to Book value | 6.36 |
| Price to Sales | 12.49 |
| Price to Cash Flow | 26.58 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|